LIVIVO - Search results -

Search results

Result 1 - 10 of total 15

Search options

Article ; Online: Knowledge of and concerns about long-acting reversible contraception among women in medication-assisted treatment for opioid use disorder.

Matusiewicz, Alexis K / Melbostad, Heidi S / Heil, Sarah H

2017 Volume 96, Issue 5, Page(s) 365–369

Abstract: Objectives: To assess interest in, concerns about and knowledge of long-acting reversible contraceptives (LARC) among women in medication-assisted treatment (MAT) for opioid use disorder who were at risk for unintended pregnancy.: Study design: Women ...

Abstract	Objectives: To assess interest in, concerns about and knowledge of long-acting reversible contraceptives (LARC) among women in medication-assisted treatment (MAT) for opioid use disorder who were at risk for unintended pregnancy. Study design: Women in MAT completed a survey on contraceptive use, attitudes and knowledge, including LARC methods, as part of eligibility screening for an ongoing trial evaluating family planning interventions for this population. Results: Eighty-three women at risk for unintended pregnancy completed the survey, and a subset of 51 completed supplemental questions about implants. All participants had heard of IUDs and 75/83 (90%) had heard of implants, but only 34/83 (41%) and 14/51 (27%) reported being likely to use IUDs and implants, respectively. Thirty-five women reported they were unlikely to use IUDs, with 29/35 (83%) citing unspecified "other reasons" for this position and 24/35 (69%) endorsing concerns about side effects. Seventeen women reported they were unlikely to use implants, with 8/17 (47%) citing "other reasons" and 9/17 (53%) and 10/17 (59%) reporting concerns about insertion and removal, respectively. Participants reported they knew "a little" about LARCs, but only their knowledge of implants was limited. Only 50/83 (60%) participants were aware of the superior effectiveness of IUDs and 26/51 (51%) were aware of the superior effectiveness of implants relative to other reversible methods. Conclusions: Participants reported relatively low interest in LARCs. Many women had unspecified reasons for not using LARCs. Participants also lacked information about LARC safety and effectiveness, especially with regard to implants. Implications: Women in medication-assisted treatment for opioid use disorder are at high risk of unintended pregnancy, yet contraceptive use is low and use of less effective methods is common. Women in MAT may benefit from efforts to increase knowledge about implants and assuage concerns about their insertion and removal as well as more general efforts to improve knowledge about the relative efficacy of LARCs. Many women in MAT endorsed unspecified "other reasons" for not using LARCs, which should be explored further.
MeSH term(s)	Adult ; Cognitive Dissonance ; Contraception Behavior ; Contraceptive Agents, Female/administration & dosage ; Contraceptive Agents, Female/adverse effects ; Contraceptive Effectiveness ; Contraceptive Prevalence Surveys ; Drug Implants/adverse effects ; Female ; Health Knowledge, Attitudes, Practice ; Humans ; Intention ; Intrauterine Devices/adverse effects ; Long-Acting Reversible Contraception/adverse effects ; Opiate Substitution Treatment ; Opioid-Related Disorders/drug therapy ; Pregnancy ; Pregnancy, Unplanned ; Vermont ; Young Adult
Chemical Substances	Contraceptive Agents, Female ; Drug Implants
Language	English
Publishing date	2017-08-02
Publishing country	United States
Document type	Journal Article
ZDB-ID	80106-9
ISSN	1879-0518 ; 0010-7824
ISSN (online)	1879-0518
ISSN	0010-7824
DOI	10.1016/j.contraception.2017.07.167
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 629: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Preliminary side effect profile, safety, and tolerability of hormonal contraception among women receiving opioid-agonist therapy.

Melbostad, Heidi S / Wachtel, Deborah S / Lipke, Kerstin A / Badger, Gary J / Matusiewicz, Alexis K / Rey, Catalina N / MacAfee, Lauren K / Dougherty, Anne K / Heil, Sarah H

Contraception

2022 Volume 110, Page(s) 16–20

Abstract: Objective(s): To characterize for the first time the side effect profile, safety, and tolerability of hormonal contraception among women receiving opioid-agonist therapy.: Study design: We conducted a secondary analysis of data collected from ... ...

Abstract	Objective(s): To characterize for the first time the side effect profile, safety, and tolerability of hormonal contraception among women receiving opioid-agonist therapy. Study design: We conducted a secondary analysis of data collected from participants in a three-arm randomized controlled trial (N = 138) aimed at increasing effective contraceptive use among women receiving opioid-agonist therapy. Participants in the 2 intervention conditions (n = 90) had free access to hormonal contraception at each of the 14 visits scheduled during the 6-month intervention. Contraceptive use and side effects were recorded at each visit; participants could change methods or discontinue use at any time. Verbatim side effects were classified using Medical Dictionary for Regulatory Activities (MedDRA) terminology. Results: Of 67 participants reporting hormonal contraceptive use, 29 (43%) initiated implants, 14 (21%) intrauterine devices, 13 (19%) combined pills, 11 (16%) progestin-only pills, 10 (15%) injectables, 1 (2%) ring, and 1 (2%) patch; the average (±standard deviation) duration of use was 129 ± 55, 129 ± 60, 108 ± 62, 102 ± 61, 111 ± 31, 145, and 18 days, respectively. A total of 321 side effects were reported by 55 (82%) participants. Fifty (75%) participants reported menstrual cycle changes/uterine bleeding, followed by headaches (16, 24%), weight gain (15, 22%), and abdominal pain or nausea/vomiting (11, 16%). No serious side effects were reported. Twelve participants (18%) changed methods and 13 (19%) discontinued all hormonal contraceptive use. Conclusion(s): The hormonal contraceptive side effects reported by this small group of women receiving opioid-agonist therapy appear consistent with those reported by the general population, was generally well-tolerated, and did not raise safety concerns. Implications: These results provide important preliminary evidence that hormonal contraceptive use produces a familiar side effect profile and is well-tolerated by women receiving opioid-agonist therapy, although studies with larger samples followed over longer periods of time with appropriate comparison conditions are needed to fully assess tolerability and safety.
MeSH term(s)	Analgesics, Opioid/adverse effects ; Contraception/methods ; Contraceptive Agents ; Female ; Hormonal Contraception ; Humans ; Intrauterine Devices ; Male ; Uterine Hemorrhage
Chemical Substances	Analgesics, Opioid ; Contraceptive Agents
Language	English
Publishing date	2022-03-11
Publishing country	United States
Document type	Journal Article ; Randomized Controlled Trial ; Research Support, U.S. Gov't, P.H.S. ; Research Support, N.I.H., Extramural
ZDB-ID	80106-9
ISSN	1879-0518 ; 0010-7824
ISSN (online)	1879-0518
ISSN	0010-7824
DOI	10.1016/j.contraception.2022.02.013
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 629: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Changes in alcohol use following the transition to motherhood: Findings from the National Epidemiologic Survey on Alcohol and Related Conditions.

Matusiewicz, Alexis K / Ilgen, Mark A / Bohnert, Kipling M

Drug and alcohol dependence

2016 Volume 168, Page(s) 204–210

Abstract: Background: Little is known about the impact of motherhood on alcohol use beyond the acute reductions observed in pregnancy. This study characterizes changes in alcohol use for women who did and did not become mothers over three years.: Methods: Data ...

Abstract	Background: Little is known about the impact of motherhood on alcohol use beyond the acute reductions observed in pregnancy. This study characterizes changes in alcohol use for women who did and did not become mothers over three years. Methods: Data are from the National Epidemiologic Survey of Alcohol and Related Conditions (NESARC). Participants were female respondents aged 18-44 years who did not have children and were not pregnant at wave 1, and who reported having at least one drink in the year prior to wave 1 (n=2118). Women were classified as mothers (n=325) if they reported having a child between waves 1 and 2, and non-mothers if they did not (n=1793). At each wave, participants provided information on past-year frequency of alcohol use and heavy episodic drinking, and usual number of alcoholic beverages consumed per occasion. Results: At baseline, women who did and did not become mothers reported similar levels of alcohol use. Women who became mothers reported significant reductions in alcohol use indicators from wave 1 to wave 2 (i.e., 22 fewer drinking days, 15 fewer heavy drinking days, 1 less drink per occasion), whereas women who did not become mothers showed a modest increase in alcohol use frequency (i.e., 7 more drinking days). Motherhood remained significantly associated with reductions in alcohol use after adjusting for sociodemographic variables and baseline alcohol use. Conclusions: The transition to motherhood is associated with marked reductions in alcohol consumption. Similar reductions were not observed for women who did not become mothers.
MeSH term(s)	Adolescent ; Adult ; Alcohol Drinking/psychology ; Alcohol Drinking/trends ; Alcoholic Beverages ; Female ; Humans ; Mothers/psychology ; Young Adult
Language	English
Publishing date	2016-09-05
Publishing country	Ireland
Document type	Journal Article
ZDB-ID	519918-9
ISSN	1879-0046 ; 0376-8716
ISSN (online)	1879-0046
ISSN	0376-8716
DOI	10.1016/j.drugalcdep.2016.08.635
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 1310: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article: Delay Discounting and Preference Reversals by Cigarette Smokers.

Yi, Richard / Matusiewicz, Alexis K / Tyson, Antonio

The Psychological record

2016 Volume 66, Issue 2, Page(s) 235–242

Abstract: Quit attempts made by smokers that result in relapse to smoking are conceptualized in behavioral economics as preference reversals, in which preference for a larger-later outcome switches to preference for a smaller-sooner outcome. Though preference ... ...

Abstract	Quit attempts made by smokers that result in relapse to smoking are conceptualized in behavioral economics as preference reversals, in which preference for a larger-later outcome switches to preference for a smaller-sooner outcome. Though preference reversals are predicted by models of delay discounting, we are aware of no human research that has explicitly established that rate of delay discounting is associated with preference reversals. The present study attempted to establish this connection. Assessments of delay discounting of hypothetical money rewards at two magnitudes ($50, $1000) were examined from forty-five smokers, as well as a novel preference reversal task designed to determine when a preference reversal would occur for the same amounts of hypothetical money. Results from the preference reversal task were used to classify participants as predicted high, moderate, and low discounters, and rates of delay discounting were compared between these classifications at each magnitude. Statistically significant differences were observed between predicted high and low discounters in both magnitude conditions, and between predicted high and moderate discounters in the $1000 magnitude condition. Correlations between delay discounting and preference reversal amongst moderate discounters, though in the predicted direction, did not reach statistical significance. The overall pattern of results are consistent with the indication that rate of delay discounting is associated with the timing of preference reversals.
Language	English
Publishing date	2016-06-01
Publishing country	Switzerland
Document type	Journal Article
ZDB-ID	2066929-X
ISSN	2163-3452 ; 0033-2933
ISSN (online)	2163-3452
ISSN	0033-2933
DOI	10.1007/s40732-016-0165-4
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article ; Online: Current directions in laboratory studies of personality pathology: Examples from borderline personality disorder, psychopathy, and schizotypy.

Matusiewicz, Alexis K / McCauley, Katherine L / McCarthy, Julie M / Bounoua, Nadia / Lejuez, C W

Personality disorders

2018 Volume 9, Issue 1, Page(s) 2–11

Abstract: Much of the earliest research on personality pathology was observational and descriptive in nature, drawing heavily on subjective self-reports, however, the last 20 years have seen a surge of interest in laboratory-based studies. Laboratory research ... ...

Abstract	Much of the earliest research on personality pathology was observational and descriptive in nature, drawing heavily on subjective self-reports, however, the last 20 years have seen a surge of interest in laboratory-based studies. Laboratory research offers a number of benefits for researchers interested in personality disorders and personality pathology including the opportunities to use objective performance-based and behavioral measures, reveal the neuropsychological and biobehavioral processes that may help shape the experience and behavior of individuals with personality disorders, and create experimental designs that allow researchers to systematically explore the effect of context on emotional, behavioral and cognitive responding. Along with these benefits, laboratory research on personality disorders has its share of methodological and interpretive challenges and raise several key questions, including (a) How should we interpret findings that diverge from theory-driven predictions? (b) How do we reconcile discrepant results from subjective and performance-based assessments? and (c) Are these discrepancies due to methodological artifact, a hallmark of the disorder, or cause for theoretical reconsideration? The goal of this article is to review studies aimed at answering a key research question in the domains of borderline personality disorder, psychopathy, and schizotypy. Our review highlights significant progress in laboratory research on personality disorders, and identifies challenges that must be addressed to capitalize on the promise of laboratory methods. It is our hope that future experimental work proceeds with an eye toward theoretical coherence, methodological rigor, ecological validity, and clinical utility. (PsycINFO Database Record
MeSH term(s)	Antisocial Personality Disorder/physiopathology ; Biomedical Research/standards ; Borderline Personality Disorder/physiopathology ; Humans ; Schizotypal Personality Disorder/physiopathology
Language	English
Publishing date	2018-01-08
Publishing country	United States
Document type	Journal Article ; Review
ZDB-ID	2540907-4
ISSN	1949-2723 ; 1949-2715
ISSN (online)	1949-2723
ISSN	1949-2715
DOI	10.1037/per0000236
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article ; Online: Coping and violence perpetration in a residential substance use disorder treatment sample.

Bonar, Erin E / Matusiewicz, Alexis K / Bohnert, Amy S B / Ilgen, Mark A / Sanborn, Michelle L / Chermack, Stephen T

Journal of addictive diseases

2018 Volume 37, Issue 1-2, Page(s) 23–33

Abstract: ... ...

Abstract	Background
MeSH term(s)	Adaptation, Psychological ; Adult ; Cross-Sectional Studies ; Female ; Humans ; Male ; Residential Treatment/statistics & numerical data ; Substance-Related Disorders/psychology ; Violence/statistics & numerical data ; Young Adult
Language	English
Publishing date	2018-06-01
Publishing country	England
Document type	Journal Article ; Research Support, N.I.H., Extramural
ZDB-ID	1077616-3
ISSN	1545-0848 ; 1055-0887
ISSN (online)	1545-0848
ISSN	1055-0887
DOI	10.1080/10550887.2018.1479611
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 1696: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Efficacy and Cost-Benefit of Onsite Contraceptive Services With and Without Incentives Among Women With Opioid Use Disorder at High Risk for Unintended Pregnancy: A Randomized Clinical Trial.

Heil, Sarah H / Melbostad, Heidi S / Matusiewicz, Alexis K / Rey, Catalina N / Badger, Gary J / Shepard, Donald S / Sigmon, Stacey C / MacAfee, Lauren K / Higgins, Stephen T

JAMA psychiatry

2021 Volume 78, Issue 10, Page(s) 1071–1078

Abstract: Importance: Rates of in utero opioid exposure continue to increase in the US. Nearly all of these pregnancies are unintended but there has been little intervention research addressing this growing and costly public health problem.: Objective: To test ...

Abstract	Importance: Rates of in utero opioid exposure continue to increase in the US. Nearly all of these pregnancies are unintended but there has been little intervention research addressing this growing and costly public health problem. Objective: To test the efficacy and cost-benefit of onsite contraceptive services with and without incentives to increase prescription contraceptive use among women with opioid use disorder (OUD) at high risk for unintended pregnancy compared with usual care. Design, setting, and participants: A randomized clinical trial of 138 women ages 20 to 44 years receiving medication for OUD who were at high risk for an unintended pregnancy at trial enrollment between May 2015 and September 2018. The final assessment was completed in September 2019. Data were analyzed from October 2019 to March 2021. Participants received contraceptive services at a clinic colocated with an opioid treatment program. Interventions: Participants were randomly assigned to receive 1 of 3 conditions: (1) usual care (ie, information about contraceptive methods and community health care facilities) (n = 48); (2) onsite contraceptive services adapted from the World Health Organization including 6 months of follow-up visits to assess method satisfaction (n = 48); or (3) those same onsite contraceptive services plus financial incentives for attending follow-up visits (n = 42). Main outcomes and measures: Verified prescription contraceptive use at 6 months with a cost-benefit analysis conducted from a societal perspective. Results: In this randomized clinical trial of 138 women (median age, 31 years [range, 20-44 years]), graded increases in verified prescription contraceptive use were seen in participants assigned to usual care (10.4%; 95% CI, 3.5%-22.7%) vs contraceptive services (29.2%; 95% CI, 17.0%-44.1%) vs contraceptive services plus incentives (54.8%; 95% CI, 38.7%-70.2%) at the 6-month end-of-treatment assessment (P < .001 for all comparisons). Those effects were sustained at the 12-month final assessment (usual care: 6.3%; 95% CI, 1.3%-17.2%; contraceptive services: 25.0%; 95% CI, 13.6%-39.6%; and contraceptive services plus incentives: 42.9%; 95% CI, 27.7%-59.0%; P < .001) and were associated with graded reductions in unintended pregnancy rates across the 12-month trial (usual care: 22.2%; 95% CI, 11.2%-37.1%; contraceptive services: 16.7%; 95% CI, 7.0%-31.4%; contraceptive services plus incentives: 4.9%; 95% CI, 0.6%-15.5%; P = .03). Each dollar invested yielded an estimated $5.59 (95% CI, $2.73-$7.91) in societal cost-benefits for contraceptive services vs usual care, $6.14 (95% CI, $3.57-$7.08) for contraceptive services plus incentives vs usual care and $6.96 (95% CI, $0.62-$10.09) for combining incentives with contraceptive services vs contraceptive services alone. Conclusions and relevance: In this randomized clinical trial, outcomes with both onsite contraceptive service interventions exceeded those with usual care, but the most efficacious, cost-beneficial outcomes were achieved by combining contraceptive services with incentives. Colocating contraceptive services with opioid treatment programs offers an innovative, cost-effective strategy for preventing unintended pregnancy. Trial registration: ClinicalTrials.gov Identifier: NCT02411357.
MeSH term(s)	Adult ; Contraception/economics ; Contraceptive Agents/administration & dosage ; Cost-Benefit Analysis ; Drug Prescriptions ; Family Planning Services/economics ; Family Planning Services/organization & administration ; Female ; Follow-Up Studies ; Humans ; Motivation ; Opioid-Related Disorders/therapy ; Outcome and Process Assessment, Health Care ; Patient Compliance ; Patient Satisfaction ; Risk ; Young Adult
Chemical Substances	Contraceptive Agents
Language	English
Publishing date	2021-07-14
Publishing country	United States
Document type	Journal Article ; Randomized Controlled Trial ; Research Support, N.I.H., Extramural
ZDB-ID	2701203-7
ISSN	2168-6238 ; 2168-622X
ISSN (online)	2168-6238
ISSN	2168-622X
DOI	10.1001/jamapsychiatry.2021.1715
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Ui I Zs.235: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: The Relationship Between Non-Medical Use of Prescription Opioids and Sex Work Among Adults in Residential Substance Use Treatment.

Matusiewicz, Alexis K / Ilgen, Mark A / Bonar, Erin E / Price, Amanda / Bohnert, Amy S B

Journal of substance abuse treatment

2016 Volume 64, Page(s) 24–28

Abstract: High rates of substance use (e.g., alcohol, cocaine, heroin) have been documented among individuals who engage in sex work (SW), and adults seeking substance use disorder (SUD) treatment frequently report prior engagement in SW. Non-medical use of ... ...

Abstract	High rates of substance use (e.g., alcohol, cocaine, heroin) have been documented among individuals who engage in sex work (SW), and adults seeking substance use disorder (SUD) treatment frequently report prior engagement in SW. Non-medical use of prescription opioids (NMUPO) has increased over the last decade, but little is known about the relationship between NMUPO with sex exchange. The purpose of this study was to describe the prevalence of recent SW among patients at a large residential SUD treatment center and examine the association between NMUPO and SW. Approximately 14% of 588 adults reported involvement in SW in the month prior to treatment. NMUPO was more common among those with a history of SW (95% of sex workers vs. 74% of non-sex-workers), and this association remained statistically significant after controlling for demographic factors, other substance use and psychiatric symptom severity (odds ratio=3.38). SW is relatively common among patients in residential SUD treatment, and is associated with greater psychiatric severity and more extensive substance use, including alarming rates of NMUPO. Addiction treatment for individuals involved in SW may benefit from the addition of content related to NMUPO.
MeSH term(s)	Adult ; Female ; Humans ; Male ; Michigan/epidemiology ; Opioid-Related Disorders/epidemiology ; Opioid-Related Disorders/psychology ; Opioid-Related Disorders/rehabilitation ; Prescription Drug Misuse ; Prevalence ; Residential Facilities ; Severity of Illness Index ; Sex Work/statistics & numerical data ; Substance Abuse Treatment Centers
Language	English
Publishing date	2016-02-13
Publishing country	United States
Document type	Journal Article ; Research Support, N.I.H., Extramural
ZDB-ID	605923-5
ISSN	1873-6483 ; 0740-5472
ISSN (online)	1873-6483
ISSN	0740-5472
DOI	10.1016/j.jsat.2016.01.010
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 2017: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Statistical equivalence and test-retest reliability of delay and probability discounting using real and hypothetical rewards.

Matusiewicz, Alexis K / Carter, Anne E / Landes, Reid D / Yi, Richard

Behavioural processes

2013 Volume 100, Page(s) 116–122

Abstract: Delay discounting (DD) and probability discounting (PD) refer to the reduction in the subjective value of outcomes as a function of delay and uncertainty, respectively. Elevated measures of discounting are associated with a variety of maladaptive ... ...

Abstract	Delay discounting (DD) and probability discounting (PD) refer to the reduction in the subjective value of outcomes as a function of delay and uncertainty, respectively. Elevated measures of discounting are associated with a variety of maladaptive behaviors, and confidence in the validity of these measures is imperative. The present research examined (1) the statistical equivalence of discounting measures when rewards were hypothetical or real, and (2) their 1-week reliability. While previous research has partially explored these issues using the low threshold of nonsignificant difference, the present study fully addressed this issue using the more-compelling threshold of statistical equivalence. DD and PD measures were collected from 28 healthy adults using real and hypothetical $50 rewards during each of two experimental sessions, one week apart. Analyses using area-under-the-curve measures revealed a general pattern of statistical equivalence, indicating equivalence of real/hypothetical conditions as well as 1-week reliability. Exceptions are identified and discussed.
MeSH term(s)	Adult ; Choice Behavior ; Female ; Humans ; Male ; Middle Aged ; Reproducibility of Results ; Reward ; Time Factors
Language	English
Publishing date	2013-08-14
Publishing country	Netherlands
Document type	Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
ZDB-ID	196999-7
ISSN	1872-8308 ; 0376-6357
ISSN (online)	1872-8308
ISSN	0376-6357
DOI	10.1016/j.beproc.2013.07.019
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 4104: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (2.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Contingency Management Interventions for HIV, Tuberculosis, and Hepatitis Control Among Individuals With Substance Use Disorders: A Systematized Review.

Herrmann, Evan S / Matusiewicz, Alexis K / Stitzer, Maxine L / Higgins, Stephen T / Sigmon, Stacey C / Heil, Sarah H

Journal of substance abuse treatment

2016 Volume 72, Page(s) 117–125

Abstract: Hepatitis, HIV and tuberculosis are significant and costly public health problems that disproportionately affect individuals with substance use disorders (SUDs). Incentive-based treatment approaches (i.e., contingency management; CM) are highly effective ...

Abstract	Hepatitis, HIV and tuberculosis are significant and costly public health problems that disproportionately affect individuals with substance use disorders (SUDs). Incentive-based treatment approaches (i.e., contingency management; CM) are highly effective at reducing drug use. The primary aim of this report is to review the extant literature that examines the efficacy of CM interventions for the prevention, diagnosis and treatment of hepatitis, HIV and tuberculosis among individuals with SUDs. A literature search identified 23 controlled studies on this topic. In approximately 85% of the studies, CM produced significantly better adherence to prevention, diagnosis and treatment-related medical services, with adherence rates averaging almost 35% higher among patients receiving incentives vs. control condition participants. Findings from these studies parallel the results of a meta-analysis of CM interventions for the treatment of SUDs. The results also suggest that the principles that underlie the efficacy of CM generalize across infectious disease and substance abuse treatment behaviors. The application of additional principles from the literature on CM for treatment of SUDs to interventions targeting infectious disease control would be beneficial. Further development and dissemination of these interventions has the potential to greatly impact public health.
MeSH term(s)	Behavior Therapy/methods ; Behavior Therapy/statistics & numerical data ; Comorbidity ; HIV Infections/diagnosis ; HIV Infections/drug therapy ; HIV Infections/epidemiology ; HIV Infections/prevention & control ; Hepatitis/diagnosis ; Hepatitis/drug therapy ; Hepatitis/epidemiology ; Hepatitis/prevention & control ; Humans ; Reward ; Substance-Related Disorders/epidemiology ; Substance-Related Disorders/therapy ; Tuberculosis/diagnosis ; Tuberculosis/drug therapy ; Tuberculosis/epidemiology ; Tuberculosis/prevention & control
Language	English
Publishing date	2016-06-24
Publishing country	United States
Document type	Journal Article ; Meta-Analysis ; Review ; Research Support, N.I.H., Extramural
ZDB-ID	605923-5
ISSN	1873-6483 ; 0740-5472
ISSN (online)	1873-6483
ISSN	0740-5472
DOI	10.1016/j.jsat.2016.06.009
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 2017: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

To top

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

Order via subito

More links

Kategorien

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito